ConductScience.org, home

Paper36911825

Hederagenin suppresses glioma cell biological activities via Nur77 in vitro study.

Dai Y and 5 others. Food Sci Nutr, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Hederagenin suppresses glioma cell biological activities via Nur77 in vitro study. Papers, record 36911825. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36911825

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hederagenin suppresses glioma cell biological activities via Nur77 in vitro study.
PubMed
Journal
Food Sci Nutr
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.84
iCite
Revised in PubMed
2024-09-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dai YYuxiang
2Masra NNgarmbaye
3Zhou LLu
4Yu CChen
5Jin WWei
6Ni HHongbinhttps://orcid.org/0000-0002-8585-0340

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136911825Hederagenin suppresses glioma cell biological activities via Nur77 in vitro study.Food Sci Nutr2023https://conductscience.org/library/papers/36911825PubMed
228485251Salvia miltiorrhiza extract dihydrotanshinone induces apoptosis and inhibits proliferation of glioma cells.Bosn J Basic Med Sci2017https://conductscience.org/library/papers/28485251PubMed
38646688Expression of tissue factor correlates with grade of malignancy in human glioma.Cancer1996https://conductscience.org/library/papers/8646688PubMed
433402591Optimum patient selection for irinotecan-containing regimens in metastatic colorectal cancer: Literature review and lessons from clinical practice.Indian J Cancer2021https://conductscience.org/library/papers/33402591PubMed
528741098Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy.Cancer Chemother Pharmacol2017https://conductscience.org/library/papers/28741098PubMed
620660371Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.Cancer Res2010https://conductscience.org/library/papers/20660371PubMed
733319659The Role of EGCG in Breast Cancer Prevention and Therapy.Mini Rev Med Chem2021https://conductscience.org/library/papers/33319659PubMed
820847229Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells.FASEB J2011https://conductscience.org/library/papers/20847229PubMed
928001084Resveratrol as an anti-cancer agent: A review.Crit Rev Food Sci Nutr2018https://conductscience.org/library/papers/28001084PubMed
10270758866-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation.J Neuroinflammation2016https://conductscience.org/library/papers/27075886PubMed
1126393939Bioassay Guided Fractionation Identified Hederagenin as a Major Cytotoxic Agent from Cyclocarya paliurus Leaves.Planta Med2016https://conductscience.org/library/papers/26393939PubMed
1211983153Nuclear hormone receptors in T lymphocytes.Cell2002https://conductscience.org/library/papers/11983153PubMed
1333537093Hypoxia-induced Nur77 activates PI3K/Akt signaling via suppression of Dicer/let-7i-5p to induce epithelial-to-mesenchymal transition.Theranostics2021https://conductscience.org/library/papers/33537093PubMed
1422814889Triterpene acids from Euscaphis japonica and assessment of their cytotoxic and anti-NO activities.Planta Med2012https://conductscience.org/library/papers/22814889PubMed
1532284763Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis.J Cancer2020https://conductscience.org/library/papers/32284763PubMed
1626267321The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.Oncotarget2015https://conductscience.org/library/papers/26267321PubMed
1725342273Hederagenin from the leaves of ivy (Hedera helix L.) induces apoptosis in human LoVo colon cells through the mitochondrial pathway.BMC Complement Altern Med2014https://conductscience.org/library/papers/25342273PubMed
1831718182Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.J Nat Prod2019https://conductscience.org/library/papers/31718182PubMed
1926476750Hederagenin as a triterpene template for the development of new antitumor compounds.Eur J Med Chem2015https://conductscience.org/library/papers/26476750PubMed
2029335864Ethanol Extract of Lycopodium serratum Thunb. Attenuates Lipopolysaccharide-Induced C6 Glioma Cells Migration via Matrix Metalloproteinase-9 Expression.Chin J Integr Med2018https://conductscience.org/library/papers/29335864PubMed

See all 27 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40871546Recent Progress in Health Benefits of Hederagenin and Its Glycosides.Molecules2025https://conductscience.org/library/papers/40871546PubMed
40142049Current Progress of Hederagenin and Its Derivatives for Disease Therapy (2017-Present).Molecules2025https://conductscience.org/library/papers/40142049PubMed
39910395The role of natural products targeting macrophage polarization in sepsis-induced lung injury.Chin Med2025https://conductscience.org/library/papers/39910395PubMed
39383136Hederagenin regulates the migration and invasion of hepatocellular carcinoma cells through FOXO signaling pathway.PLoS One2024https://conductscience.org/library/papers/39383136PubMed
38962311An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives.Front Pharmacol2024https://conductscience.org/library/papers/38962311PubMed
37955689Hederagenin protects against myocardial ischemia-reperfusion injury via attenuating ALOX5-mediated ferroptosis.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/37955689PubMed
36911825Hederagenin suppresses glioma cell biological activities via Nur77 in vitro study.Food Sci Nutr2023https://conductscience.org/library/papers/36911825PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene
TCF126938PubTator's text mininghttps://conductscience.org/library/genes/6938NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36911825

GET https://conductscience.org/api/papers/v1/36911825/references?page=2